What does Iwatani do?
Iwatani sells energy and gas. It pipes and delivers LPG and sells cassette-gas stoves and canisters to homes and small businesses, and it supplies oxygen, nitrogen, argon, helium and hydrogen to factories, hospitals and electronics makers. Customers pay through gas volumes, equipment sales and long-term supply contracts.
Two things make it unusual. It is the only company in Japan that produces, ships and dispenses liquid hydrogen end to end, and it is the country's largest helium importer. It also runs a materials arm that trades rare earths, mineral sands and titanium.
The business runs in three segments — Integrated Energy (LPG, cassette gas, city gas, hydrogen retail), Industrial Gases & Machinery (air-separation gases, helium, hydrogen), and Materials (rare earths, PET resin, stainless, electronic materials). FY3/26 revenue was ¥908.5bn, up 2.9%, split roughly 41% / 32% / 24% across the three.
The stock trades near ¥1,995, about 10x earnings, 1.05x book, on a 2.4% yield, for a widely-held ¥459bn company that has raised its dividend for years. But operating profit fell 17% in FY3/26 as helium prices and LPG import costs squeezed the base, and reported net income was flattered by a one-off gain on selling the old Tokyo head office.
So the question is whether the cash-generative gas base can fund the hydrogen and critical-minerals build without letting returns drift. This profile works through five steps: the price regime, the live debates, the inflections in ownership, customers and the edge, the disclosure and capital levers, and a valuation.
What has driven the stock over the past two years?
Iwatani earns thin margins on large volumes: household and industrial gas, plus a materials arm that trades rare earths and PET resin. Much of what it sells sits inside Japan's energy-security and critical-minerals agenda, so government policy and commodity prices move the shares as much as the company's own results do.
01 · THE TRADING-HOUSE RE-RATING Through 2024 the shares rode the wave that lifted Japan's trading houses, helped by Berkshire's stakes and by hopes for hydrogen. Iwatani also built a stake of about 21% in Cosmo Energy Holdings, an oil refiner, which the market read as an ambitious energy bet. The stock climbed toward its 24-month high.
02 · PEAK ¥2,445 The shares topped out in mid-2024, just before a four-for-one stock split took effect on October 1, 2024. From there, cooling enthusiasm for the trading-house trade and a softer earnings outlook started to pull the price back.
03 · THE APRIL-2025 CRASH In early April 2025 global markets sold off hard on new US tariffs. Iwatani, exposed to trade and industrial demand, fell with them to a trough of ¥1,148 on April 7, roughly half its 2024 peak. Nothing company-specific broke; the fall was macro.
04 · WHERE IT STANDS NOW From that low the shares have recovered about 74% to ¥1,994.5, helped by the hydrogen and critical-minerals story and a broad market rebound. The stock is still about 18% below its 2024 peak, so the round trip is not complete.
Live Investor Debates
Three debates decide the read: whether FY3/26's lower operating profit is a cyclical trough or a structural weakness, whether the liquid-hydrogen near-monopoly is an asset or a money pit, and how much the critical-minerals push is really worth.
Operating profit fell 17% to ¥38.3bn, but net income rose 18% to ¥47.7bn. The gap came from a gain on selling the former Tokyo head office and from equity earnings on the ~21% Cosmo Energy stake — items that sit below operating profit.
Iwatani is the only company in Japan that makes, ships and dispenses liquid hydrogen, and it runs the country's largest network of hydrogen stations. The business is small and loss-making today, funded by the cash it earns from LPG and industrial gases.
Iwatani's Materials arm trades rare earths, mineral sands from Australia and titanium from Norway. In March 2025 it joined France's Caremag heavy-rare-earth project alongside JOGMEC, the Japanese state resource agency, with a long-term contract for the metals used in EV and defense magnets.
What is changing in who owns it, who buys from it, and the edge?
Foreign holders reached about 20% of the register by March 2026, up from roughly 11% in 2019; Norway's sovereign fund trimmed out of the top ten and State Street entered. Index flows and the trading-house re-rating drew the global money in. That points to more return-focused owners who will press for capital efficiency. Next check: the pace of any cross-holding unwind.
MUFG, Resona and Nippon Life still hold about 6% between them as static policy stakes, a legacy of old lending relationships. It is a block that could be sold down, which would free cash and widen the float. Next check: any disclosed reduction.
Iwatani built a stake of about 21% in Cosmo Energy Holdings, buying 19.9% from the Murakami activist funds in December 2023 and crossing the equity-method threshold in March 2024. Capital is tied up in non-core listed equity, though it now adds ¥10.9bn of equity earnings a year. Next check: a clear strategic rationale, or a move to monetize it.
Industrial Gases & Machinery revenue rose 6.4%, led by air-separation gas to electronics and optical-fiber makers investing in capacity. That is the highest-quality, contract-based demand holding up while energy wobbles. Next check: the semiconductor capex cycle.
The Caremag rare-earth contract pairs Iwatani with JOGMEC under a Japan-France critical-minerals accord, because Japan wants magnet metals sourced outside China. The buyer of last resort is becoming the Japanese state, which is unusually durable demand. Next check: contracted tonnage and first delivery.
The 1.2m-household direct-sales LPG base is disaster-resilient; underlying demand erodes as homes electrify with heat pumps and the population falls, but Iwatani keeps the reported base growing toward a 1.3m FY2027 target by buying dealers. The cash cow is defended by M&A, not collapsing. Next check: household count and churn.
Specialty-gas operating profit fell about ¥5.75bn on a weak helium market. Helium is scarce, but its price is cyclical, so even a scarce-input edge does not shield margin from the commodity cycle. Next check: helium price recovery.
The liquid-hydrogen network is the deepest edge and the least profitable, because the hydrogen market is still forming. Iwatani is paying now for an option that may pay later. Next check: a dated, subsidy-free breakeven.
Iwatani moved LPG inventory to weighted-average costing, and a ~3-month lag between import price and selling price still swings margin. Reported operating profit is noisy, so the cleaner read is operating profit excluding the LPG price effect. Next check: that ex-LPG trend.
Disclosure & Capital Levers
Three levers can move the stock: whether Iwatani unwinds its large securities book and lifts returns, whether the PLAN27 hydrogen and critical-minerals spend converts to profit, and whether operating profit recovers toward guidance in FY3/27.
Scenario Pathways
Snapshot ¥1,994.5 (14 Jul 2026), on FY3/26 operating profit of ¥38.3bn, FY3/27 guidance of ¥48.8bn, and an enterprise value of ¥679bn. Scenario ranges are JII estimates, not company guidance or price targets.
- Helium and LPG stay depressed
- Securities book de-rated 20–30%
- Hydrogen impaired, no breakeven
- PLAN27 targets dropped
- OP recovers to ¥48.8bn guide
- Gas peers hold 10–12x
- Securities at fair value
- Dividend keeps rising
- OP toward ¥60bn
- Cross-holdings unwound, capital returned
- Hydrogen breakeven in sight
- Critical-minerals re-rating
This is not investment advice.
Japan Investor Interface Co., Ltd. ("JII") is an investor-relations (IR) consultancy. JII is not a registered investment advisor, financial advisor, broker-dealer, or securities firm in any jurisdiction. JII is not registered as a Financial Instruments Business Operator (金融商品取引業者) under Japan's Financial Instruments and Exchange Act. JII does not have a 投資助言・代理業 registration and does not provide investment advice or solicit the purchase, sale, or holding of any security.
JII Compounders is an editorial publication. Each profile is an analytical study of how publicly disclosed information about a Japanese listed company has been received by the market. It is intended for educational and research purposes for IR professionals, finance students, journalists, and other readers interested in corporate disclosure practice. Nothing in this publication constitutes a recommendation, opinion, suggestion, or solicitation to buy, sell, or hold any security, derivative, or other financial instrument. Price targets, scenario ranges, multiples, and comparable-company references are illustrative of analytical method only and must not be interpreted as JII's investment opinion. JII does not have an investment opinion on any security discussed.
No reliance. The information presented may be incomplete, out of date, or incorrect. Forward-looking statements are inherently uncertain. Past price performance does not indicate future results. Estimates and scenario figures are not predictions and may not be achieved. JII makes no representation or warranty, express or implied, regarding the accuracy, completeness, timeliness, or reliability of any information in this publication.
No fiduciary or advisory relationship. Reading this publication does not create any advisory, fiduciary, or professional relationship between you and JII. Before making any investment, tax, accounting, legal, or other decision, you should consult qualified, licensed advisors in your jurisdiction and conduct your own independent due diligence based on primary disclosures issued by the company concerned.
Conflicts & positions. JII may provide paid IR diagnostic, translation, or interpretation services to Japanese listed companies, including companies discussed in this publication. JII does not trade in or hold positions in the securities of companies profiled. Where a JII engagement exists with a profiled company, that fact will be disclosed at the top of the profile.
Trademarks & data. Company names, logos, tickers, and product names referenced are the property of their respective owners. Share-price data is licensed from third-party providers. TradingView is a trademark of TradingView, Inc. All rights reserved.
本資料は、日本の金融商品取引法に基づく投資助言・代理業ではなく、特定の有価証券の売買その他の取引の勧誘・推奨を目的とするものではありません。本資料は教育・研究を目的とした分析記事であり、JII（株式会社ジャパン・インベスター・インターフェース）は、本資料の内容に基づく投資判断について一切の責任を負いません。投資の判断はご自身の責任と独立した調査に基づいて行ってください。